Mersana Therapeutics Inc

NASDAQ:MRSN   4:00:00 PM EDT
4.49
+0.19 (+4.42%)
: $4.50 +0.01 (+0.22%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)544.66M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$7.93 Million
Adjusted EPS-$0.18
See more estimates
10-Day MA$4.68
50-Day MA$4.25
200-Day MA$2.60
See more pivots

Mersana Therapeutics Inc Stock, NASDAQ:MRSN

840 Memorial Drive, Cambridge, Massachusetts 02139
United States of America
Phone: +1.617.498.0020
Number of Employees: 123

Description

Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592. The company was founded by Mikhail Papisov in 2001 and is headquartered in Cambridge, MA.